A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque Psoriasis

Clinical trial NCT07765628 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07765628
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2026-08-06
Primary completion: 2027-02-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.